Diagnostics Pipeline: Abbott Launches SimpleScreen CRC, a Blood-Based Colorectal Cancer Test
New test intends to draw in patients who may not complete specimen collection for blockbuster Cologuard assay
Author Information
New test intends to draw in patients who may not complete specimen collection for blockbuster Cologuard assay
The FDA is reclassifying product codes NYQ, MVD, OWE, and PNK so they can be approved using the 510(k) submission process
The deal gives the oncology-focused Veracyte a boost in bladder cancer detection
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
If Profusa pulls off the purchase, it will give the startup its first revenue source
Company also announces distribution of newly approved Alzheimer’s assay
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
At-home sample collections can be mailed to a clinical laboratory
The company will fold into Leica Biosystems after the transaction closes at the end of this year
The startup is trying to close the care gap between female and male patients